Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IBC 2025 | The relationship between CHIP & MBL with the risk of progression to lymphoid/myeloid malignancies

Susan Slager • 13 Mar 2025
IBC 2025
General

Susan Slager, PhD, Mayo Clinic, Rochester, MN, comments on the findings of a study examining the relationship between monoclonal B-cell lymphocytosis (MBL) and clonal hematopoiesis of indeterminate potential (CHIP) and the risk of developing lymphoid and myeloid malignancies. This interview took place at the 3rd Intercepting Blood Cancers (IBC) Workshop held in Nice, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Susan Slager

The clinical relevance of MBL: impact on risk of developing lymphoid & other malignancies 1:07
The clinical relevance of MBL: impact on risk of developing lymphoid & other malignancies
Susan Slager • 13 Mar 2025
A study investigating the impact of inherited variants on CLL prognosis 1:06
A study investigating the impact of inherited variants on CLL prognosis
Susan Slager • 29 Aug 2024
A polygenic risk score to determine a patient’s predisposition to CLL 3:32
A polygenic risk score to determine a patient’s predisposition to CLL
Susan Slager • 29 Aug 2024

Related Videos

Opportunities and challenges for real-time AI decision support in transplant care 4:47
Opportunities and challenges for real-time AI decision support in transplant care
Amin Turki • 5 Sep 2025
How AI and digital innovation are transforming transplant care 4:02
How AI and digital innovation are transforming transplant care
Amin Turki • 5 Sep 2025
Bringing clinical trials to the community: current approaches at Sarah Cannon Research Institute 1:01
Bringing clinical trials to the community: current approaches at Sarah Cannon Research Institute
Krish Patel • 4 Sep 2025
Stem cell transplant in 2025: latest advances, improving GvHD, and key clinical trials 8:12
Stem cell transplant in 2025: latest advances, improving GvHD, and key clinical trials
Alexandra Gomez-Arteaga • 10 Sep 2025
The content of VJHemOnc is intended for healthcare professionals